Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer.
Schmid
L
L
Abteilung für Onkologie und Hämatologie, Kantonsspital, St. Gallen, Switzerland.
Thürlimann
B
B
Müller
M
M
Senn
H J
HJ
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006098:Granulocytes / Q000187:drug effects; D006402:Hematologic Diseases / Q000139:chemically induced; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D010976:Platelet Count / Q000187:drug effects; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012074:Remission Induction
D006454:Hemoglobins; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor